1. Garne E, Haeusler M, Barisic I, et al. Congenital diaphragmatic hernia: evaluation of prenatal diagnosis in
20 European regions. Ultrasound Obstet Gynecol. 2002;19(4):329–333.
2. Montalva L, Antounians L, Zani A. Pulmonary hypertension secondary to congenital diaphragmatic hernia:
factors and pathways involved in pulmonary vascular remodeling. Pediatr Res. 2019;85(6):754–768.
3. Friedmacher F, Pakarinen MP, Rintala RJ. Congenital diaphragmatic hernia: a scientometric analysis of the
global research activity and collaborative networks. Pediatr Surg Int. 2018;34(9):907–917.
4. Spaggiari E, Stirnemann JJ, Sonigo P, Khen-Dunlop N, De Saint Blanquat L, Ville Y. Prenatal prediction of pulmonary arterial hypertension in congenital diaphragmatic hernia. Ultrasound Obstet Gynecol.
2015;45(5):572–577.
5. Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension guidelines from the American
Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037–2099.
6. McHoney M, Hammond P. Role of ECMO in congenital diaphragmatic hernia. Arch Dis Child-Fetal
Neonatal Ed. 2018;103(2):F178-F181.
7. Saura L, Castanon M, Prat J, et al. Impact of fetal intervention on postnatal management of congenital
diaphragmatic. Eur J Pediatr Surg. 2007;17(6):404–407.
8. Araujo Junior E, Tonni G, Martins WP, Ruano R. Procedure-related complications and survival following
Fetoscopic Endotracheal Occlusion (FETO) for severe congenital diaphragmatic hernia: systematic review
and meta-analysis in the FETO Era. Eur J Pediatr Surg. 2017;27(4):297–305.
9. Sluiter I, Reiss I, Kraemer U, de Krijger R, Tibboel D, Rottier RJ. Vascular abnormalities in human
newborns with pulmonary hypertension. Expert Rev Respir Med. 2011;5(2):245–256.
10. Mous DS, Buscop-van Kempen MJ, Wijnen RMH, Tibboel D, Rottier RJ. Changes in vasoactive pathways
in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapy. Respir Res. 2017;18(1):187.
11. Mizuno M, Miki R, Moriyama Y, et al. The role of E2F8 in the human placenta. Mol Med Rep.
2019;19(1):293–301.
12. Moriyama Y, Kotani T, Ushida T, et al. Altered proteomic profile in umbilical arterial serum from mothers
with schizophrenia. Schizophr Res. 2018;197:615–617.
13. Pan HT, Guo MX, Xiong YM, et al. Differential proteomic analysis of umbilical artery tissue from preeclampsia patients, using iTRAQ isobaric tags and 2D nano LC-MS/MS. J Proteomics. 2015;112:262–273.
14. Karasinski J, Wrobel K, Corrales Escobosa AR, Konopka A, Bulska E, Wrobel K. Allium cepa L. Response
to sodium selenite (Se(IV)) studied in plant roots by a LC-MS-based proteomic approach. J Agric Food
Chem. 2017;65(19):3995–4004.
15. Ramirez Segovia AS, Wrobel K, Acevedo Aguilar FJ, Corrales Escobosa AR, Wrobel K. Effect of Cu(ii)
354
Asuka Tachi et al
16. 17. 18. 19. 20. 21. 22. 23. 24. on in vitro glycation of human serum albumin by methylglyoxal: a LC-MS-based proteomic approach.
Metallomics. 2017;9(2):132–140.
Queloz PA, Crettaz D, Thadikkaran L, et al. Proteomic analyses of amniotic fluid: potential applications
in health and diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850(1-2):336–342.
Kononikhin AS, Starodubtseva NL, Chagovets VV, et al. Exhaled breath condensate analysis from intubated
newborns by nano-HPLC coupled to high resolution MS. J Chromatogr B Analyt Technol Biomed Life Sci.
2017;1047:97–105.
Santos M, Moura RS, Gonzaga S, Nogueira-Silva C, Ohlmeier S, Correia-Pinto J. Embryonic essential
myosin light chain regulates fetal lung development in rats. Am J Respir Cell Mol Biol. 2007;37(3):330–338.
Peiro JL, Oria M, Aydin E, et al. Proteomic profiling of tracheal fluid in an ovine model of congenital
diaphragmatic hernia and fetal tracheal occlusion. Am J Physiol Lung Cell Mol Physiol. 2018;315(6):L1028L1041.
Cheung AK, Parker CJ, Wilcox L. Effects of two types of cobra venom factor on porcine complement
activation and pulmonary artery pressure. Clin Exp Immunol. 1989;78(2):299–306.
Yao L, Yang YX, He GH, Ou CQ, Wang L, Liu KX. Global proteomics deciphered novel-function of
osthole against pulmonary arterial hypertension. Scientific Reports. 2018;8:13.
Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, et al. Genomic assessment of a multikinase
inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics. 2008;33(2):278–291.
Sumida T, Naito AT, Nomura S, et al. Complement C1q-induced activation of beta-catenin signalling causes
hypertensive arterial remodelling. Nat Commun. 2015;6:12.
Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM. Complement C3 deficiency attenuates
chronic hypoxia-induced pulmonary hypertension in mice. PLoS One. 2011;6(12):e28578.
...
論文の公開元へ
